Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Platelet
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Anti-inflammatory drugs=== Some drugs used to treat inflammation have the unwanted side effect of suppressing normal platelet function. These are the [[non-steroidal anti-inflammatory drugs]] (NSAIDS). [[Aspirin]] irreversibly disrupts platelet function by inhibiting [[cyclooxygenase]]-1 (COX1), and hence normal hemostasis. The resulting platelets are unable to produce new cyclooxygenase because they have no DNA. Normal platelet function does not return until the use of aspirin has ceased and enough of the affected platelets have been replaced by new ones, which can take over a week. [[Ibuprofen]], another [[NSAID]], does not have such a long duration effect, with platelet function usually returning within 24 hours,<ref>{{cite journal |date=April 2005 |title=Summaries for patients. Platelet function after taking Ibuprofen for 1 week |journal=Annals of Internal Medicine |volume=142 |issue=7 |pages=Iβ54 |doi=10.7326/0003-4819-142-7-200504050-00004 |pmid=15809457 |doi-access=free}}<!-- |access-date=2008-08-26 --></ref> and taking ibuprofen before aspirin prevents the irreversible effects of aspirin.<ref name="pmid6411052">{{cite journal |vauthors=Rao GH, Johnson GG, Reddy KR, White JG |title=Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin |journal=Arteriosclerosis |volume=3 |issue=4 |pages=383β8 |date=1983 |pmid=6411052 |doi=10.1161/01.ATV.3.4.383 |s2cid=3229482 |doi-access=free}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)